Startseite Inflammation, vascular biology, endothelium, and oxidative stress
Artikel Öffentlich zugänglich

Inflammation, vascular biology, endothelium, and oxidative stress

Veröffentlicht/Copyright: 21. Oktober 2021
Veröffentlichen auch Sie bei De Gruyter Brill

Published Online: 2021-10-21
Published in Print: 2021-11-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Committees
  3. Contents
  4. Speakers Abstracts
  5. Educational Workshop Abstracts
  6. Advanced technologies, including new biomarker discovery
  7. Analytical technologies and applications
  8. Artificial intelligence - Informatics
  9. Atherosclerosis, including lipids and other risk markers
  10. Audit
  11. Autoimmune diseases , including allergy
  12. Bioinformatics, including data management
  13. Biomarkers in cancer
  14. Bone metabolism
  15. Cardiovascular diseases, including cardiac markers
  16. Case report
  17. Clinical Studies - Outcomes
  18. Diabetes, obesity, metabolic syndrome
  19. Education and Training in Laboratory Medicine
  20. Endocrinology, not including diabetes
  21. Evidence based medicine, including Guidelines
  22. Gastrointestinal diseases, including hepatic and pancreatic diseases
  23. Genetic diseases
  24. Haematology, including haemostasis
  25. Inflammation, vascular biology, endothelium, and oxidative stress
  26. Inherited disorders, metabolic disorders and rare diseases
  27. Kidney diseases
  28. Laboratory and Sports medicine
  29. Laboratory Management, Accreditation, Quality Assurance, performance specification
  30. Microbiology - Infectious diseases including COVID 19
  31. Molecular diagnostics, including epigenetics
  32. Neonatal and paediatric laboratory medicine, including prenatal testing
  33. Neurological diseases
  34. Nutrition, including vitamins and trace elements
  35. Other
  36. Personalised Medicine, including pharmacogenetics
  37. Point of Care testing, critical care, emergency medicine.
  38. Reference intervals and decision limits
  39. Total Testing Process, including standardisation, preanalytical process
  40. Toxicology, including therapeutic drug monitoring
  41. Urinalysis
Heruntergeladen am 12.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2021-5022/html
Button zum nach oben scrollen